Fresenius Medical Care US Finance III Inc, a subsidiary of the global healthcare company Fresenius SE & Co. KGaA, was established in the United States to finance the operations and growth of Fresenius Medical Care North America. The company primarily provides financial services, including project financing, for the healthcare sector and specializes in dialysis services and products.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| FMEGR 1.88% 2026-12-01 USDFresenius Medical Care US Finance III Inc | Germany | 2026-12-01 | 1.875 | 4.52 |
| FMEGR 1.88% 2026-12-01 USDFresenius Medical Care US Finance III Inc | Germany | 2026-12-01 | 1.875 | 4.53 |
| FMEGR 2.38% 2031-02-16 USDFresenius Medical Care US Finance III Inc | Germany | 2031-02-16 | 2.375 | 4.89 |
| FMEGR 2.38% 2031-02-16 USDFresenius Medical Care US Finance III Inc | Germany | 2031-02-16 | 2.375 | 4.84 |
| FMEGR 3.00% 2031-12-01 USDFresenius Medical Care US Finance III Inc | Germany | 2031-12-01 | 3.000 | 5.05 |
| FMEGR 3.00% 2031-12-01 USDFresenius Medical Care US Finance III Inc | United States | 2031-12-01 | 3.000 | 5.05 |
| FMEGR 3.75% 2029-06-15 USDFresenius Medical Care US Finance III Inc | Germany | 2029-06-15 | 3.750 | 4.63 |
| FMEGR 3.75% 2029-06-15 USDFresenius Medical Care US Finance III Inc | Germany | 2029-06-15 | 3.750 | 4.61 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Fresenius Medical Care US Finance III Inc has been active in the bond market, issuing its first bonds in 2015 to support the expansion of its healthcare facilities. Significant issuances include a $500 million bond offering in 2019, which was part of a refinancing strategy that improved its overall debt maturity profile. Currently, yields on its bonds are competitive within the healthcare sector, reflecting strong demand and favorable market conditions. Notably, the company occasionally issues bonds with call features, allowing it to manage refinancing risks effectively as market conditions evolve.